129 related articles for article (PubMed ID: 2541753)
1. The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients.
Ferner RE; Wilson D; Paterson JR; Wilkinson R; Rawlins MD
Br J Clin Pharmacol; 1989 Mar; 27(3):337-42. PubMed ID: 2541753
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the effects of captopril and enalapril on skin responses to intradermal bradykinin and skin blood flow in the human forearm.
Li Kam Wa TC; Cooke ED; Turner P
Br J Clin Pharmacol; 1993 Jan; 35(1):8-13. PubMed ID: 8448072
[TBL] [Abstract][Full Text] [Related]
3. Absence of potentiation of the skin response to intradermal bradykinin by a long-acting angiotensin converting enzyme inhibitor, trandolapril, at conventional antihypertensive dosage in human volunteers: a double-blind, randomized, cross-over, placebo-controlled trial.
Li Kam Wa TC; Cooke ED; Beacham J; Turner P
Postgrad Med J; 1992 Sep; 68(803):742-5. PubMed ID: 1480537
[TBL] [Abstract][Full Text] [Related]
4. Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme.
Ferner RE; Simpson JM; Rawlins MD
Br Med J (Clin Res Ed); 1987 May; 294(6580):1119-20. PubMed ID: 3034372
[TBL] [Abstract][Full Text] [Related]
5. The effect of sulindac on dermal responses to bradykinin in normal subjects given an angiotensin converting enzyme inhibitor.
Ferner RE; Kamali F; Rawlins MD
Br J Clin Pharmacol; 1990 Mar; 29(3):363-5. PubMed ID: 2310660
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
Brown NJ; Ryder D; Gainer JV; Morrow JD; Nadeau J
J Pharmacol Exp Ther; 1996 Nov; 279(2):703-12. PubMed ID: 8930174
[TBL] [Abstract][Full Text] [Related]
7. Effect of enalapril on the skin response to bradykinin in man.
Fuller RW; Warren JB; McCusker M; Dollery CT
Br J Clin Pharmacol; 1987 Jan; 23(1):88-90. PubMed ID: 3028457
[TBL] [Abstract][Full Text] [Related]
8. Effect of captopril on skin blood flow following intradermal bradykinin measured by laser Doppler flowmetry.
Li Kam Wa TC; Almond NE; Cooke ED; Turner P
Eur J Clin Pharmacol; 1989; 37(5):471-5. PubMed ID: 2532136
[TBL] [Abstract][Full Text] [Related]
9. Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: the effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamine.
Anderson MW; deShazo RD
J Allergy Clin Immunol; 1990 May; 85(5):856-8. PubMed ID: 2185292
[TBL] [Abstract][Full Text] [Related]
10. The effect of indomethacin and enalapril on the cutaneous response to bradykinin.
McAlpine LG; Thomson NC
Br J Clin Pharmacol; 1989 Jun; 27(6):870-2. PubMed ID: 2547411
[TBL] [Abstract][Full Text] [Related]
11. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
[TBL] [Abstract][Full Text] [Related]
12. New aspects on inflammatory reactions and cough following inhibiton of angiotensin converting enzyme.
Lindgren BR
Acta Physiol Scand Suppl; 1988; 573():1-60. PubMed ID: 2466391
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous blood flow changes and weal induced by intradermal bradykinin following pretreatment with indomethacin and captopril.
Wa TC; Cooke ED; Turner P
Eur J Clin Pharmacol; 1993; 44(1):41-5. PubMed ID: 8436153
[TBL] [Abstract][Full Text] [Related]
14. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
Elmarakby AA; Williams JM; Imig JD; Pollock JS; Pollock DM
Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788
[TBL] [Abstract][Full Text] [Related]
15. The potentiation of cardiodepressant and hypotensive effects of bradykinin by enalapril and captopril both in vitro and in vivo.
Prostran M; Samardzić R; Todorović Z; Jovanović-Mićić D; Japundzić N; Beleslin BD
Gen Pharmacol; 1991; 22(6):995-1000. PubMed ID: 1810815
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
17. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin-induced cough reflex markedly increases in patients with cough associated with captopril and enalapril.
Katsumata U; Sekizawa K; Ujiie Y; Sasaki H; Takishima T
Tohoku J Exp Med; 1991 Jun; 164(2):103-9. PubMed ID: 1721246
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme inhibitors potentiate the bronchoconstriction induced by substance P in the guinea-pig.
Subissi A; Guelfi M; Criscuoli M
Br J Pharmacol; 1990 Jul; 100(3):502-6. PubMed ID: 1697196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
